Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study.

CancerMath OSNA clinically negative lymph node decision support system early breast cancer sentinel lymph node

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
19 Jan 2021
Historique:
received: 20 12 2020
revised: 14 01 2021
accepted: 15 01 2021
entrez: 22 1 2021
pubmed: 23 1 2021
medline: 23 1 2021
Statut: epublish

Résumé

In the absence of lymph node abnormalities detectable on clinical examination or imaging, the guidelines provide for the dissection of the first axillary draining lymph nodes during surgery. It is not always possible to arrive at surgery without diagnostic doubts, and machine learning algorithms can support clinical decisions. The web calculator CancerMath (CM) allows you to estimate the probability of having positive lymph nodes valued on the basis of tumor size, age, histologic type, grading, expression of estrogen receptor, and progesterone receptor. We collected 993 patients referred to our institute with clinically negative results characterized by sentinel lymph node status, prognostic factors defined by CM, and also human epidermal growth factor receptor 2 (HER2) and Ki-67. Area Under the Curve (AUC) values obtained by the online CM application were comparable with those obtained after training its algorithm on our database. Nevertheless, by training the CM model on our dataset and using the same feature, we reached a sensitivity median value of 72%, whereas the online one was equal to 46%, despite a specificity reduction. We found that the addition of the prognostic factors Her2 and Ki67 could help improve performances on the classification of particular types of patients with the aim of reducing as much as possible the false positives that lead to axillary dissection. As showed by our experimental results, it is not particularly suitable for use as a support instrument for the prediction of metastatic lymph nodes on clinically negative patients.

Identifiants

pubmed: 33477893
pii: cancers13020352
doi: 10.3390/cancers13020352
pmc: PMC7833376
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet Oncol. 2013 May;14(6):500-15
pubmed: 23540561
JAMA. 2011 Feb 9;305(6):569-75
pubmed: 21304082
Cancer Res Treat. 2017 Oct;49(4):1088-1096
pubmed: 28161935
Ann Surg Oncol. 2018 Oct;25(10):3011-3018
pubmed: 29968027
Breast. 2014 Aug;23(4):378-84
pubmed: 24630617
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Am J Clin Pathol. 2002 Jun;117(6):916-21
pubmed: 12047143
PLoS One. 2018 Jul 6;13(7):e0200100
pubmed: 29979736
PLoS One. 2018 Apr 26;13(4):e0195877
pubmed: 29698418
PLoS One. 2014 Jan 31;9(1):e86309
pubmed: 24497942
Sci Rep. 2016 Feb 15;6:21196
pubmed: 26875677
BMC Bioinformatics. 2020 Mar 11;21(Suppl 2):91
pubmed: 32164532
Cancer Manag Res. 2020 Jul 08;12:5549-5559
pubmed: 32753968
Lancet Oncol. 2015 Apr;16(4):e173-80
pubmed: 25846097
Arch Med Sci. 2016 Dec 1;12(6):1239-1246
pubmed: 27904514
Clin Cancer Res. 2005 Aug 15;11(16):5686-93
pubmed: 16115904
Ann Oncol. 2015 Aug;26(8):1533-46
pubmed: 25939896
J Clin Oncol. 2007 Aug 20;25(24):3670-9
pubmed: 17664461
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Clin Breast Cancer. 2020 Jun;20(3):e281-e289
pubmed: 32147404
Front Oncol. 2019 Sep 30;9:980
pubmed: 31632912
J Clin Oncol. 2010 Sep 1;28(25):3929-36
pubmed: 20679600
J Clin Med. 2019 Jun 21;8(6):
pubmed: 31234363
Clin Cancer Res. 2007 Aug 15;13(16):4807-16
pubmed: 17699859
Phys Med Biol. 2018 Dec 14;63(24):245014
pubmed: 30523819
Cancer. 2009 Nov 1;115(21):5071-83
pubmed: 19658184
Breast Cancer Res Treat. 2019 Dec;178(3):665-681
pubmed: 31471837
Cancer. 2003 Mar 1;97(5):1321-31
pubmed: 12599241
Phys Med. 2019 Aug;64:1-9
pubmed: 31515007
Cancer. 2009 Nov 1;115(21):5095-107
pubmed: 19670458
Sci Rep. 2019 Mar 14;9(1):4429
pubmed: 30872652
Hum Pathol. 1994 Apr;25(4):337-42
pubmed: 8163266
BMC Cancer. 2016 Oct 21;16(1):820
pubmed: 27769212
Acta Oncol. 2020 Jun;59(6):689-695
pubmed: 32148141
BMC Cancer. 2017 Aug 23;17(1):561
pubmed: 28835223
Ann Surg Oncol. 2021 Jan;28(1):310-319
pubmed: 32583195
Oncotarget. 2018 Feb 5;9(14):11619-11630
pubmed: 29545924
Cancers (Basel). 2020 Feb 06;12(2):
pubmed: 32041094
Diagnostics (Basel). 2020 Sep 17;10(9):
pubmed: 32957690
BMC Cancer. 2019 Jan 10;19(1):45
pubmed: 30630443
Lancet Oncol. 2010 Oct;11(10):927-33
pubmed: 20863759
Cancer Imaging. 2020 Sep 15;20(1):65
pubmed: 32933585
PLoS One. 2017 Feb 27;12(2):e0169962
pubmed: 28241044
Eur Radiol. 2018 Feb;28(2):582-591
pubmed: 28828635
Oncol Lett. 2020 Sep;20(3):2469-2476
pubmed: 32782565

Auteurs

Annarita Fanizzi (A)

Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Domenico Pomarico (D)

Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Angelo Paradiso (A)

Oncologia Medica Sperimentale, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Samantha Bove (S)

Dipartimento di Matematica, Università degli Studi di Bari, 70121 Bari, Italy.

Sergio Diotaiuti (S)

Struttura Semplice Dipartimentale di Chirurgia, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Vittorio Didonna (V)

Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Francesco Giotta (F)

Unità Operativa Complessa di Oncologia Medica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Daniele La Forgia (D)

Struttura Semplice Dipartimentale di Radiologia Senologica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Agnese Latorre (A)

Unità Operativa Complessa di Oncologia Medica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Maria Irene Pastena (MI)

Unità Operativa Complessa di Anatomia Patologica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Pasquale Tamborra (P)

Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Alfredo Zito (A)

Unità Operativa Complessa di Anatomia Patologica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Vito Lorusso (V)

Unità Operativa Complessa di Oncologia Medica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Raffaella Massafra (R)

Struttura Semplice Dipartimentale di Fisica Sanitaria, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.

Classifications MeSH